Back
EAPC Premium Access

First real world experience with the novel lipid-lowering drug PCSK9 inhibitor evolocumab in patients undergoing lipid apheresis: 1-year follow up

Session: Moderated Poster Session II
Topic: Lipids
Speaker: Mr M. Poudel (Bielefeld, DE)
Event: EuroPrevent 2018

Congress Presentation

Add to my library

Like

About the speaker

Mr Madan Raj Poudel

University Clinic OWL, Bielefeld (Germany)
2 presentations
1 follower

9 more presentations in this session

Trimetazidine in the management of primary microvascular angina

Speaker: Associate Professor I. Leonova (Saint Petersburg, RU)

Access
Abstract
Like
Thumbnail

Prediction of subtle left ventricular systolic dysfunction in homozygous and heterozygous familial hypercholesterolemia: genetic analyses and speckle tracking echocardiography study

Speaker: Doctor E. Saracoglu (Kocaeli, TR)

Access
Abstract
Like
Thumbnail

Exercise-induced changes in LDL and HDL levels are correlated with the exercise-induced CRP response- NEEDED 2014

Speaker: Doctor C. Erevik (Stavanger, NO)

Access
Abstract
Slides
Like
Thumbnail

Differences in risk factors for three types of stroke: UK prospective study and meta-analyses.

Speaker: Doctor L. Wright (Oxford, GB)

Access
Abstract
Slides
Like
Thumbnail

Comparative analyses of trends in hospitalisations for coronary heart disease subgroups in England and Australia

Speaker: Doctor L. Nedkoff (Perth, AU)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Moderated Poster Session II

Speakers: Mr M. Poudel, Associate Professor I. Leonova, Doctor E. Saracoglu, Doctor C. Erevik, Doctor L. Wright...
Access
Like
Thumbnail

About the event

Image

EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources